Newsfeeds - Spark Newswire

4 minute read

Options

8 Health Care Stocks With Unusual Options Alerts In Today’s Session

Today, 10:30 PM

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. Unusual trading activity could push option prices to exaggerated or underestimated levels.

APLS

1 minute read

Codexis, Merck Extend Supply Pact For Enzyme Used To Manufacture Sitagliptin

By Vandana Singh

Today, 10:30 PM

Codexis Inc (NASDAQ:CDXS) has amended and extended its agreement with Merck & Co Inc (NYSE:MRK) to license and supply a proprietary enzyme used…

CDXS

1 minute read

Is Moderna’s Stock Still Cheap?

By Adam Eckert

Today, 10:30 PM

Moderna Inc (NASDAQ: MRNA) traded higher Thursday after the company announced it's developing a single-dose vaccine that combines a booster against COVID-19 and a booster against flu during its R&D Day.

MRK

1 minute read

Coca-Cola And Merck Lead The Dow Jones Lower

By Henry Khederian

Today, 10:30 PM

U.S. indices were trading lower Thursday following a drop in U.S. weekly jobless claims.

2 minute read

Codexis, Merck Amend And Extend Supply Agreement For Enzyme Used In Manufacture Of Sitagliptin

By Benzinga Newsdesk

Today, 10:30 PM

Codexis, Inc. (NASDAQ:CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, announced the amendment and extension of its agreement with Merck, known as MSD outside the United States and

CDXS

2 minute read

Moderna Shares Gain Amid R&D Day Presentations: What You Need To Know

By Shanthi Rexaline

Today, 10:30 PM

Moderna, Inc. (NASDAQ: MRNA), a biotech that rose to prominence with its successful coronavirus vaccine program, is holding its fifth annual R&D day Thursday.

AZN

5 minute read

Downgrades On Economy And Pandemic Pharmaceuticals

By JJ Kinahan

Today, 10:30 PM

The futures markets are pointing to a lower open on Wednesday, weighed down by European markets. The uncertainty around infrastructure, stimulus, and other government spending appears to be on investor’s minds.

AAPL

1 minute read

News

Merck To Present New Data From Its Broad Oncology Portfolio and Pipeline at ESMO 2021, Including in Earlier Stages of Cancer

By Benzinga Newsdesk

Today, 10:30 PM

Pivotal Phase 3 Data for KEYTRUDA® (pembrolizumab) in Stage II Melanoma (KEYNOTE-716) and Recurrent, Persistent or Metastatic Cervical Cancer (KEYNOTE-826) Selected for ESMO Presidential Symposium Sessions and

MRK

1 minute read

Illumina, Merck Join Hands For Homologous Recombination Deficiency CDx, Research Assay

By Vandana Singh

Today, 10:30 PM

Illumina Inc (NASDAQ:ILMN) and Merck & Co Inc (NYSE:MRK) provided more details on their partnership to develop and commercialize tests that gauge genetic…

AZN

6 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 7, 2021

By Benzinga Insights

Today, 10:30 PM

AMGN